Alnylam Pharmaceuticals Is Launched and Ready for More

Alnylam Pharmaceuticals (NASDAQ: ALNY) updated investors last month on how the launch of Onpattro, its first drug that was approved to treat transthyretin-mediated amyloidosis (ATTR), was going at the J.P. Morgan Healthcare Conference.